More delays and slow sell down continues. What ever happened to Billabong? What an incredibly frustrating stock.
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market